Long Covid news: where to find reliable updates
Keeping up with Long Covid news is particularly difficult. The field is moving quickly, new research is published constantly, and coverage is often either sensationalised or shaped by broader political attitudes to COVID-19.
This page is not a feed of the latest headlines. It is a guide to where reliable Long Covid news actually lives, and how to read it without burning through energy you do not have to spare.
How to spot reliable news
Most health news coverage of Long Covid is poor. Stories tend to overclaim on the basis of small preliminary studies, present private clinics’ promotional material as research news, or frame the condition through a political lens rather than a clinical one.
Before giving a story your attention, it is worth checking a few things:
- Who funded the research? Reliable studies are usually funded by universities, major research charities, or public research councils. Be wary of work funded only by a clinic or company that sells the treatment being promoted.
- Has the research been peer-reviewed and published? Press releases about findings that have not yet been peer-reviewed — or that have only been presented at a conference — should be read as provisional.
- Is it a single study, or part of a broader pattern? Individual studies often contradict each other. Reliable reporting puts new findings in the context of what else is known.
- How is the story framed? Responsible coverage talks about ‘findings’, ‘associations’, ‘possible mechanisms’, or ‘early evidence’. Be cautious of language like ‘breakthrough’, ‘miracle’, or ‘cure’ — and equally cautious of coverage claiming the condition is overstated or not real.
Where to follow Long Covid news
You do not need to read specialist journals to stay informed. A small number of established organisations summarise new research in accessible language and apply appropriate caution to their reporting.
Research and science updates
- Patient-Led Research Collaborative. A patient-run research group that has published widely on Long Covid symptoms and biomarkers. Often the earliest to identify patterns that later appear in academic literature.
- Open Medicine Foundation. Funds research into post-infectious illnesses, including Long Covid, and publishes plain-language updates on its work.
- Solve M.E. A US organisation focused on research and advocacy for ME/CFS and Long Covid, offering webinars and newsletters covering both.
Advocacy and patient-focused sources
- Long Covid SOS. A UK patient-led advocacy group tracking policy developments, research funding, and NHS provision.
- Long Covid Kids. A UK charity focused on children and young people with Long Covid — an area that receives particularly little mainstream coverage.
- MEAction. A global patient-led advocacy network covering both ME/CFS and Long Covid, with chapters across multiple countries.
Reading research claims carefully
Even good reporting can make a study sound more conclusive than it is.
- A single study is not proof. Findings need to be replicated — ideally by other teams, in other populations — before they can be considered reliable.
- Correlation is not causation. A study finding that people with Long Covid differ from healthy controls in some way does not mean that difference caused the illness.
- Preliminary is the most important word in research news. Early findings are the starting point of a long process. Most do not hold up.
Long Covid research is published at a higher rate than either ME/CFS or fibromyalgia research. That is good news for the field overall, but it means the proportion of findings that will not survive replication is particularly high. A calmer reading of a single study is usually a more accurate one.
Advocacy and research funding
Several areas of ongoing advocacy are worth following through the organisations above:
- Research funding. Public funding for Long Covid research has been significant since 2020, but is uneven across countries and has faced criticism in some settings for prioritising rehabilitation studies over biomedical mechanism research.
- NHS clinic provision. NICE NG188 sets the framework for Long Covid care in the UK, but availability of specialised NHS Long Covid clinics varies considerably by region. Patient organisations are pushing for more consistent provision.
- Recognition in benefits systems. Long Covid is increasingly recognised in UK disability and benefits assessments, but the process remains inconsistent. The organisations listed above track developments and provide guidance.
Progress on these fronts is slower than many people with Long Covid need it to be. The organisations listed above are the most reliable way to stay informed.